Similar articles

• Morphology, Attenuation, Size, and Structure (MASS) criteria: assessing response and predicting clinical outcome in metastatic renal cell carcinoma on antiangiogenic targeted therapy.

  Smith AD, Shah SN, Rini BI, Lieber ML, Remer EM. Smith AD, et al. AJR Am J Roentgenol. 2010 Jun;194(6):1470-8. doi: 10.2214/AJR.09.3456. AJR Am J Roentgenol. 2010. PMID: 20489085
• Utilizing pre-therapy clinical schema and initial CT changes to predict progression-free survival in patients with metastatic renal cell carcinoma on VEGF-targeted therapy: a preliminary analysis.

  Smith AD, Shah SN, Rini BI, Lieber ML, Remer EM. Smith AD, et al. Urol Oncol. 2013 Oct;31(7):1283-91. doi: 10.1016/j.urolonc.2011.08.010. Epub 2011 Sep 29. Urol Oncol. 2013. PMID: 21956044
• Acute Kidney Injury after Partial Nephrectomy: Role of Parenchymal Mass Reduction and Ischemia and Impact on Subsequent Functional Recovery.

  Zhang Z, Zhao J, Dong W, Remer E, Li J, Demirjian S, Zabell J, Campbell SC. Zhang Z, et al. Eur Urol. 2016 Apr;69(4):745-752. doi: 10.1016/j.eururo.2015.10.023. Epub 2015 Oct 30. Eur Urol. 2016. PMID: 26525838
• Using Genetic Variation to Predict and Extend Long-term Kidney Transplant Function.

  Simmonds MJ. Simmonds MJ. Transplantation. 2015 Oct;99(10):2038-48. doi: 10.1097/TP.0000000000000836. Transplantation. 2015. PMID: 26262502 Review.
• Can donor implantation renal biopsy predict long-term renal allograft outcome?

  El-Husseini A, Sabry A, Zahran A, Shoker A. El-Husseini A, et al. Am J Nephrol. 2007;27(2):144-51. doi: 10.1159/000099944. Epub 2007 Feb 16. Am J Nephrol. 2007. PMID: 17308376 Review.